NDRA

Elite Trades From Anywhere Elite Trades All Summer

$100 Off Your First Year Get Elite For Just $199.50

Jun 25, 9:55 AMENDRA Life Sciences signs definitive deal to merge subsidiary with ASP Isotopes’ Noble Africa, forming Noble Africa Inc. with holders owning about 3%

Peers: ADVB BIAF ISPC MBAI NOTV XWEL MDXH PRPO QUCY XGN

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	6.35M
Enterprise Value	6.45M
Income	-7.30M
Sales	0.00M
Book/sh	1.44
Cash/sh	0.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	11
IPO	Jun 30, 2017

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	3.47
P/C	17.65
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.64
Current Ratio	0.64
Debt/Eq	0.26
LT Debt/Eq	0.18
Option/Short	No / Yes

EPS (ttm)	-8.15
EPS next Y	-3.04
EPS next Q	-0.84
EPS this Y	60.36%
EPS next Y	14.12%
EPS next 5Y	-
EPS past 3/5Y	89.62% 79.05%
Sales past 3/5Y	- -
EPS Y/Y TTM	98.32%
Sales Y/Y TTM	-
EPS Q/Q	41.18%
Sales Q/Q	-
Earnings	May 18 BMO
EPS/Sales Surpr.	11.38% -

Insider Own	46.89%
Insider Trans	0.00%
Inst Own	7.06%
Inst Trans	-6.22%
ROA	-220.99%
ROE	-412.60%
ROIC	-345.41%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	3.51%
SMA50	-1.74%
SMA200	1.50%
Trades

Shs Outstand	1.24M
Shs Float	0.67M
Short Float	3.27%
Short Ratio	0.76
Short Interest	0.02M
52W High	11.96 -58.19%
52W Low	2.96 68.92%
Volatility	27.84% 13.93%
ATR (14)	0.69
RSI (14)	50.28
Beta	-0.04
Rel Volume	0.69
Avg Volume	28.79K
Volume	19,969

Perf Week	-3.47%
Perf Month	-9.42%
Perf Quarter	14.94%
Perf Half Y	-1.96%
Perf YTD	10.38%
Perf Year	39.66%
Perf 3Y	-99.80%
Perf 5Y	-99.99%
Perf 10Y	-
Recom	1.00
Target Price	25.00
Prev Close	4.99
Price	5.00
Change	0.20%

Jun-25-26 12:11PM	ASP Isotopes To Merge Noble Africa With A Unit Of ENDRA A Look At The Key Contours Of The Deal (Stocktwits) -31.42%
09:51AM	ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing (Business Wire)
May-18-26 08:00AM	ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update (Business Wire) +7.13%
May-14-26 08:00AM	ENDRA Life Sciences Reports Multi-Site Validation of TAEUS Liver Device Demonstrating MRI-like Accuracy and Reproducibility (Business Wire)
Mar-31-26 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (Business Wire)
08:00AM	Loading…
Mar-25-26 08:00AM	ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value (Business Wire) +8.38%
Mar-03-26 10:15AM	NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision (Zacks)
Feb-26-26 08:00AM	ENDRAs TAEUS Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care (Business Wire)
Dec-04-25 08:00AM	ENDRA's TAEUS Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use (Business Wire) -7.67%
Nov-20-25 08:00AM	ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker (Business Wire) -15.19%
Nov-17-25 08:00AM	ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results (Business Wire) -7.46%
Nov-14-25 09:25AM	Endra Life Sciences commences staking of HYPE digital asset holdings (TipRanks)
Oct-23-25 08:00AM	ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings (Business Wire) -5.88%
Oct-16-25 08:57AM	Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition (Zacks) -5.53%
Oct-13-25 08:14AM	Pulse Biosciences Unveils Promising First-in-Human Data for nPulse (Zacks) +25.31%
08:00AM	Loading…
08:00AM	ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca (Business Wire)
Aug-14-25 04:05PM	ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results (Business Wire) +9.46%
Jun-16-25 08:00AM	ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard (Business Wire)
May-15-25 04:05PM	ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results (Business Wire)
Mar-31-25 08:05AM	ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies (Business Wire)
08:00AM	ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update (Business Wire)
Jan-28-25 12:00PM	What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock (Zacks)
Nov-22-24 08:00AM	ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire)
Nov-15-24 09:24AM	ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -14.18%
Nov-12-24 08:00AM	Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting 2024 (Business Wire)
Nov-06-24 08:00AM	ENDRA Life Sciences Further Strengthens TAEUS Platform Intellectual Property with Issuance of 17th European Patent (Business Wire) -14.84%
Oct-22-24 08:00AM	ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany (Business Wire) +89.19%
Aug-28-24 04:17PM	ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements (Business Wire) -19.56%
Aug-22-24 04:14PM	ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -10.99%
Aug-16-24 08:00AM	ENDRA Life Sciences Announces Reverse Stock Split (Business Wire) -22.50%
04:05PM	Loading…
Aug-13-24 04:05PM	ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 (Business Wire)
08:00AM	ENDRA Life Sciences Announces Leadership Changes (Business Wire)
Aug-07-24 08:00AM	ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 (Business Wire)
Jun-17-24 08:11AM	Why Is ENDRA Life Sciences (NDRA) Stock Up 36% Today? (InvestorPlace) +34.17%
07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-05-24 07:35AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +63.41%
Jun-04-24 09:21AM	ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering (Business Wire) -60.83%
May-20-24 08:00AM	ENDRA Provides Update Following In-person Meeting with FDA (Business Wire)
May-15-24 03:10AM	ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-14-24 04:05PM	ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update (Business Wire)
May-07-24 08:00AM	ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024 (Business Wire) -6.41%
May-02-24 08:00AM	ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents (Business Wire) +15.48%
Apr-01-24 09:59AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.50%
Mar-29-24 06:21AM	Q4 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	NDRA Stock Earnings: ENDRA Life Sciences Beats EPS for Q4 2023 (InvestorPlace) -29.29% -30.50%
04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire)
Mar-21-24 08:00AM	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 (Business Wire) -8.76%
Feb-27-24 08:00AM	ENDRA Life Sciences Installs First TAEUS System in the UK (Business Wire)
Feb-21-24 08:00AM	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences TAEUS System (Business Wire)
Feb-14-24 08:30AM	ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe (Business Wire)
Nov-29-23 08:00AM	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS System Technology (Business Wire)
Nov-27-23 08:00AM	ENDRA Life Sciences to Participate in The Benchmark Companys 12th Annual Discovery One-on-One Investor Conference (Business Wire)
Nov-15-23 01:23PM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:05PM	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Nov-08-23 08:00AM	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents (Business Wire)
Nov-07-23 04:05PM	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023 (Business Wire)
Nov-06-23 08:00AM	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLDs The Liver Meeting 2023 (Business Wire)
Sep-07-23 08:00AM	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023 (Business Wire)
Aug-30-23 08:00AM	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA (Business Wire) +6.31%
Aug-23-23 08:00AM	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents (Business Wire)
Aug-20-23 11:20AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-15-23 06:49AM	Q2 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -8.37%
Aug-14-23 04:05PM	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update (Business Wire)
01:30PM	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA (Business Wire)
Aug-01-23 08:00AM	ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023 (Business Wire)
Jul-12-23 05:15PM	Domino's Pizza teams up with Uber for food delivery partnership (Yahoo Finance Video)
03:27PM	Stocks to Watch Wednesday: Domino's, Coty, Activision, Lucid (The Wall Street Journal)
02:42PM	Analyst Report: Domino's Pizza, Inc. (Morningstar Research)
02:01PM	Domino's stock jumps on partnership with Uber Eats (Yahoo Finance)
12:31PM	Dominos Pizza Is Todays Hottest Stock (The Wall Street Journal)
10:30AM	Domino's Pizza stock jumps on delivery partnership with Uber (Yahoo Finance Video)
09:42AM	Dominos Pizza Is This Mornings Hottest Stock (The Wall Street Journal)
07:05AM	Domino's® Introduces a New Way to Order Using Uber Eats Marketplace (PR Newswire)
Jul-06-23 04:45PM	ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023 (Business Wire)
Jun-07-23 08:00AM	Study Highlighting ENDRA Life Sciences TAEUS Technology to be Presented at EASL International Liver Congress 2023 (Business Wire) +5.33%
May-15-23 04:05PM	ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update (Business Wire) -8.57%
May-04-23 08:00AM	ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023 (Business Wire) +8.70%
May-02-23 04:01PM	ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Securities (Business Wire) +17.24% -5.29%
Apr-28-23 08:00AM	ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering (Business Wire) +24.03%
Mar-17-23 05:00AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.00%
Mar-15-23 10:32AM	Q4 2022 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-23 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Mar-07-23 04:05PM	ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023 (Business Wire)
Dec-08-22 09:55AM	Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher (Zacks) +6.79%
Dec-05-22 08:00AM	ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split (Business Wire) -12.10%
Nov-14-22 04:05PM	ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -10.22%
Nov-09-22 08:00AM	ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022 (Business Wire) -7.51%
Oct-25-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents (Business Wire)
Oct-04-22 08:00AM	ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference (Business Wire)
Sep-29-22 04:05PM	ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks (Business Wire)
Sep-06-22 08:00AM	ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences (Business Wire)
Aug-24-22 08:40AM	ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System (Business Wire) +11.62%
Aug-15-22 04:30PM	Edited Transcript of NDRA.OQ earnings conference call or presentation 15-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents) -7.87%
04:05PM	ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-08-22 10:16AM	Here's Why ENDRA Life Sciences (NASDAQ:NDRA) Must Use Its Cash Wisely (Simply Wall St.)
Aug-04-22 08:00AM	ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-02-22 08:00AM	ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices (Business Wire)
Aug-01-22 08:00AM	ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference (Business Wire) +14.63%
Jul-11-22 08:00AM	ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System (Business Wire)
Jun-28-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent (Business Wire) +7.11%

ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

CEO & ChairmanMr. Alexander Y. Tokman

CFO & SecretaryMr. Richard Jacroux

Co-FounderDr. Jonathan Behr Ph.D.

Head of OperationsMr. Scott Sober

Head of Regulatory & Clinical AffairsMr. Ziad Rouag J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Anthony DiGiandomenico	Board Member	Jun 26 '26	Proposed Sale	6.00	70,822	425,000		Jun 25 06:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

ENDRA Life Sciences Inc

Upgrade your Finviz experience